99266-22-5

Upstream product

• 636-61-3 D-Malic acid 
• 100-51-6 benzyl alcohol 

Downstream Products

• 133039-05-1 (R)-3-Hydroxy-4-(toluene-4-sulfonyloxy)-butyric acid benzyl ester 
• 133039-07-3 Toluene-4-sulfonate((R)-3-benzyloxycarbonyl-2-hydroxy-propyl)-trimethyl-ammonium; 
• 1027721-39-6 benzyl (2S,3R)-2-benzyl-3,4-dihydroxybutanoate 
• 172275-58-0 benzyl (2R,3S)-2-benzyl-3,4-epoxybutanoate 
• 152892-85-8 benzyl (2S,3R)-2-benzyl-3,4-epoxybutanoate 
• 172101-55-2 dibenzyl (2S,3R)-2-benzyl-3-hydroxysuccinate 
• 133039-03-9 (3R)-3,4-dihydroxybutyric acid benzyl ester 

Relevant academic research and scientific papers

A new, short and efficient synthesis of both enantiomers of carnitine

A short, efficient and enantioselective synthesis of both (R) and (S) enantiomers of carnitine is reported starting with (R) or (S) malic acid and involving a chemoselective reduction step.

(2R,3S)- and (2S,3R)-2-benzyl-3,4-epoxybutanoic acid as highly efficient and fast acting pseudomechanism-based inactivators for carboxypeptidase A: design, asymmetric synthesis and inhibitory kinetics

2-benzyl-3,4-epoxybutanoic acid (BEBA) was studied as an irreversible inhibitor for the zinc-containing protease, carboxypeptidase A.Of four possible stereoisomers, those having a 2R,3S- and a 2S,3R- configuration inhibited carboxypeptidase A in a time-de